You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Usher Syndromes

Showing 1 - 25 of 1,482
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Usher Syndromes Trial in Australia (NPI-001, Placebo)

Recruiting
  • Usher Syndromes
  • Brisbane, Australia
  • +3 more
Nov 16, 2022

USHer Syndrome (CRUSH) Study

Active, not recruiting
  • Usher Syndrome, Type 2A
  • +2 more
  • No intervention
  • Nijmegen, Gelderland, Netherlands
    Radboud universitair medisch centrum
Apr 28, 2022

Usher Syndrome, Retinitis Pigmentosa Trial in Portland, Paris (SAR421869)

Terminated
Has Results
  • Usher Syndrome
  • Retinitis Pigmentosa
  • Portland, Oregon
  • +1 more
Mar 30, 2022

Adaptive Optics Imaging of Outer Retinal Diseases

Recruiting
  • Retinal Degeneration
  • +9 more
  • Adaptive optics imaging
  • Bethesda, Maryland
  • +1 more
Apr 25, 2022

Retinitis Pigmentosa, Usher Syndrome Type 2, Usher Syndrome Type 3 Trial in San Francisco (NT-501, Sham)

Completed
  • Retinitis Pigmentosa
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Apr 14, 2022

Retinitis Pigmentosa, Usher Syndrome Type 2 Trial in Canada, France, United States (RNA antisense oligonucleotide for

Terminated
Has Results
  • Retinitis Pigmentosa
  • Usher Syndrome Type 2
  • RNA antisense oligonucleotide for intravitreal injection
  • Boston, Massachusetts
  • +6 more
Dec 12, 2022

Usher Syndromes Trial in Paris

Recruiting
  • Usher Syndromes
    • Paris, France
    • +3 more
    Dec 7, 2020

    Rate of Progression in USH2A-related Retinal Degeneration

    Active, not recruiting
    • Usher Syndrome, Type 2A
    • Retinitis Pigmentosa 39
      • San Francisco, California
      • +15 more
      Mar 8, 2022

      Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Dallas, Madison, London (QR-421a, Sham-procedure)

      Active, not recruiting
      • Retinitis Pigmentosa
      • +7 more
      • Dallas, Texas
      • +2 more
      Apr 21, 2022

      Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Canada, France, United States (QR-421a, Sham-procedure (dose

      Completed
      • Retinitis Pigmentosa
      • +7 more
      • QR-421a
      • Sham-procedure (dose cohort 1&2 only)
      • Boston, Massachusetts
      • +6 more
      Apr 19, 2022

      Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Worldwide (Ultevursen, Sham-procedure)

      Recruiting
      • Retinitis Pigmentosa
      • +7 more
      • San Diego, California
      • +14 more
      Jul 29, 2022

      Natural History and Genetic Studies of Usher Syndrome

      Completed
      • Retinitis Pigmentosa Syndromic
      • +4 more
        • Bethesda, Maryland
        • +1 more
        Dec 11, 2019

        Usher Syndrome, Congenital Deafness, Retinitis Pigmentosa Trial in Moscow

        Completed
        • Usher Syndrome
        • +2 more
          • Moscow, Russian Federation
          • +5 more
          Apr 1, 2019

          Natural History Study in Subjects With Usher Syndrome

          Unknown status
          • Usher Syndrome, Type 1B
            • Naples, Italy
            • +2 more
            Jan 22, 2019

            Integrated Chinese and Western Medicine Specialized Disease

            Not yet recruiting
            • Colorectal Cancer
            • Colorectal Adenoma
              • (no location specified)
              Nov 15, 2023

              Retrospective NIS to Evaluate the Patient Benefit of TES

              Active, not recruiting
              • Retinitis Pigmentosa
              • Transcorneal Electrostimulation via OkuStim System
              • Heidelberg, Germany
              • +3 more
              May 17, 2022

              Frailty Trial in Chicago (Enhanced Engagement, Standard Engagement)

              Recruiting
              • Frailty
              • Enhanced Engagement
              • Standard Engagement
              • Chicago, Illinois
                University of Chicago
              Oct 27, 2022

              Neurocutaneous Syndromes in Upper Egypt Children

              Not yet recruiting
              • Neurocutaneous Syndromes
                • (no location specified)
                Sep 10, 2023

                Cardiometabolic Health in First Time Pregnancy

                Not yet recruiting
                • Cardiometabolic Health
                • +4 more
                  • Cambridge, United Kingdom
                  • +5 more
                  May 3, 2023

                  PCDH15-Related Retinal Degeneration in Usher Syndrome 1F

                  Recruiting
                  • Retinal Degeneration
                  • +2 more
                    • San Francisco, California
                    • +7 more
                    Jan 12, 2022

                    MDS Trial in Hangzhou (IV Decitabine, Decitabine and cedazuridine, only Decitabine and cedazuridine)

                    Recruiting
                    • Myelodysplastic Syndromes
                    • IV Decitabine
                    • +2 more
                    • Hangzhou, Zhejiang, China
                      The First Affiliated Hospital,Zhejiang University School of Medi
                    Oct 23, 2023

                    Neuropathy and Anti-GFAP Antibodies

                    Active, not recruiting
                    • Neurological Diseases or Conditions
                    • Neurological Diseases Associated to Anti GFAP Antibodies
                    • Clinical examination
                    • electroneuromyography (ENMG)
                    • Lyon, France
                      Centre de référence des syndromes neurologiques paranéoplasiques
                    Feb 14, 2023

                    Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,

                    Recruiting
                    • Primary Immune Deficiency Disorder
                    • +2 more
                    • Baltimore, Maryland
                      Johns Hopkins University
                    Oct 20, 2022

                    Acute Coronary Syndromes Trial in Taipei county, (self-management, regular care)

                    Enrolling by invitation
                    • Acute Coronary Syndromes
                    • self-management
                    • regular care
                    • Taipei county,, Taiwan
                      Taipei Veterans General Hospital
                    Aug 11, 2023

                    MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)

                    Recruiting
                    • MDS/MPN
                    • Azacitidine (AZA) with Ruxolitinib
                    • Nanjing, Jiangsu, China
                      The First Affiliated Hospital of Nanjing Medical University
                    Apr 17, 2023